LMNR vs PTNM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LMNR exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. The company is suffering from a catastrophic revenue collapse (-46.90% YoY) and is operating with a negative gross margin (-3.23%), meaning it is losing money on its core production before operating expenses. With a technical trend of 0/100 and a consistent track record of missing earnings estimates (0/4 in the last year), there is no data-driven catalyst for a recovery. The current valuation is unsupported by earnings, and the dividend is unsustainable given the negative profitability.
PTNM exhibits a critical disconnect between its market price ($10.39) and its fundamental value, with a Piotroski F-Score of 4/9 indicating only mediocre stability. The Graham Number ($0.38) and Intrinsic Value ($0.21) suggest the stock is trading at a massive premium despite negative profit margins (-31.94%) and declining revenue growth (-23.90%). While the balance sheet shows decent liquidity and low leverage, the astronomical P/E (346.33) and Price/Book (48.36) ratios are unsustainable. The company is currently operating as a speculative vehicle rather than a value-driven investment.
Compare Another Pair
Related Comparisons
LMNR vs PTNM: Head-to-Head Comparison
This page compares Limoneira Company (LMNR) and Pitanium Limited (PTNM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.